Navigation Links
Quantitative Profiling of the Intrinsic Pathway of Apoptosis in Tumor Tissue Using Myriad RBM’s Multiplex ApoptosisMAP™, a New Biomarker Webinar by Xtalks
Date:11/19/2013

(PRWEB) November 19, 2013

Regulators of apoptotic cell death are potentially valuable targets for oncology and autoimmune disease. Several promising mechanism-based compounds that directly target the molecular components of apoptosis pathways are in clinical development. It is well known that inhibition of apoptosis occurs in most cancers and can occur by a variety of methods such up regulation of anti-apoptotic factors. Until now, profiling the key components of apoptosis has been limited by the laborious and semi-quantitative method of IP-western blot which is not amenable to multiplexing and is ill suited for clinical studies from limited sample amounts.

The ApoptosisMAP is a fully validated quantitative multiplex immunoassay that can quantify apoptotic biomarkers in clinical trials. It can support the pharmacodynamic action of investigational agents with companion diagnostic implications for identifying patients most likely to respond to a particular apoptosis inducer or other chemotherapeutic regimes. Join Dominic Eisinger, PhD, Director of Strategic Development, from Myriad RBM for this discussion on quantitative profiling using Myriad RBM’s Multi-Analyte Profile (MAP) platform.

For more information about this online seminar or to visit this webinar’s homepage, go to http://xtalks.com/Multiplex-ApoptosisMAP-quantitative-profiling.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com

Contact:
Michelle Tran, Marketing Manager
+1 (416) 977-6555 ext 224
mtran(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11325882.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Neogen Launches Fully Quantitative Lateral Flow Test for DON
2. USDA/GIPSA Approves Charm Sciences’ ROSA® FAST Aflatoxin Quantitative Test
3. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
4. Rigaku Publishes New Application Note for Quantitative Analysis of Stainless Steel
5. Rigku Publishes New Method for Quantitative Analysis of Cast Iron Using the ZSX Primus III+
6. Rigaku Announces Method for Quantitative Elemental Analysis of Low-Alloy Steel with the Rigaku ZSX Primus III+ WDXRF Spectrometer
7. Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks
8. Caris Life Sciences Enhances Molecular Profiling Service with Addition of ROS1 and MGMT-Methylation Biomarkers
9. Caris Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
10. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
11. Global Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) - 2013 Market Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... Feb. 23, 2017 China Biologic Products, Inc. (NASDAQ: ... plasma-based biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2016 Financial Highlights ... by 21.7% in RMB terms, or increased by 13.6% in ... same quarter of 2015. Gross profit increased ...
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
Breaking Biology Technology:
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... PANAMA CITY , Jan. 26, 2017  Crossmatch, ... today unveiled a new solution aimed at combatting fraud, ... The solution was introduced at the Action on Disaster ... a key meeting point for UN agencies and foreign ... Fraud, waste and abuse are a largely ...
Breaking Biology News(10 mins):